Therapeuticsmd (TXMD) Reports In-Line Q2 EPS

March 3, 2014 4:17 PM

Therapeuticsmd (NYSE: TXMD) reported Q2 EPS of ($0.06), in-line ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found